当前位置:首页 - 行情中心 - 泰格医药(300347) - 财务分析

泰格医药

(300347)

  

流通市值:313.40亿  总市值:476.58亿
流通股本:5.66亿   总股本:8.61亿

泰格医药(300347)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润10.92亿元,每股收益1.19元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益2470759.33万元,未分配利润945253.89万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产2878425.18万元,负债407665.85万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入5,025,868,260.753,250,444,279.631,564,143,614.716,603,120,162.78
营业总成本4,559,527,495.22,942,263,124.151,421,418,0035,610,048,004.89
其他经营收益
营业利润1,229,009,491.51444,257,860.73144,504,382.4664,419,011.51
利润总额1,222,780,755.26442,689,335.48143,625,342.84664,461,508.3
净利润1,091,681,166.46362,828,303.84109,980,847.86447,831,286.97
每股收益
其他综合收益9,646,423.7948,983,183.825,329,777.35-30,367,462.62
综合收益总额1,101,327,590.25411,811,487.66115,310,625.21417,463,824.35
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计6,350,600,808.176,206,460,726.465,895,369,481.16,299,685,225.86
非流动资产:
非流动资产合计22,433,650,978.7222,298,197,031.7522,834,223,468.1222,371,330,561.3
资产总计28,784,251,786.8928,504,657,758.2128,729,592,949.2228,671,015,787.16
流动负债:
流动负债合计2,937,853,013.043,395,689,292.773,635,724,221.913,661,852,465.12
非流动负债:
非流动负债合计1,138,805,470.531,145,266,109.011,185,258,688.81944,684,135.45
负债合计4,076,658,483.574,540,955,401.784,820,982,910.724,606,536,600.57
所有者权益(或股东权益):
归属于母公司股东权益合计21,176,338,660.520,524,441,879.1720,529,274,699.720,670,653,449.72
股东权益合计24,707,593,303.3223,963,702,356.4323,908,610,038.524,064,479,186.59
负债和股东权益合计28,784,251,786.8928,504,657,758.2128,729,592,949.2228,671,015,787.16
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计5,414,289,272.773,422,805,826.471,652,480,592.316,960,762,922.99
经营活动现金流出小计4,674,731,643.23,014,186,818.531,454,545,978.135,863,761,019.25
经营活动产生的现金流量净额739,557,629.57408,619,007.94197,934,614.181,097,001,903.74
投资活动产生的现金流量:
投资活动现金流入小计1,962,639,120.811,058,992,171.79148,932,353.842,171,059,961.71
投资活动现金流出小计1,468,932,322.791,013,102,115.39806,801,592.26,910,182,376.12
投资活动产生的现金流量净额493,706,798.0245,890,056.4-657,869,238.36-4,739,122,414.41
筹资活动产生的现金流量:
筹资活动现金流入小计1,268,284,871.591,102,396,907.23617,956,0003,586,116,727.86
筹资活动现金流出小计2,953,073,235.541,929,347,228.17721,821,806.55,288,526,955.49
筹资活动产生的现金流量净额-1,684,788,363.95-826,950,320.94-103,865,806.5-1,702,410,227.63
汇率变动对现金及现金等价物的影响2,935,487.0814,360,075.824,959,416.33-6,916,778.71
现金及现金等价物净增加额-448,588,449.28-358,081,180.78-558,841,014.35-5,351,447,517.01
期末现金及现金等价物余额1,599,905,403.561,690,412,672.061,489,652,838.492,048,493,852.84
补充资料:
现金及现金等价物的净增加额--358,081,180.78--5,351,447,517.01
最新报告期:2025-11-12
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
兴业证券孙媛媛,黄翰漾1.441.561.782025-11-12
华兴证券赵冰1.562.042.902025-10-31
西部证券李梦园1.431.621.832025-10-29
中信建投刘若飞,贺菊颖1.101.331.722025-09-17
财信证券吴号1.151.551.982025-09-01
TOP↑